{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:07:56Z","timestamp":1788926876709,"version":"build-2803163510"},"reference-count":33,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Erythromelalgia (EM) is an uncommon condition marked by recurring redness, intense burning sensations, and elevated limb warmth. This syndrome can be significantly debilitating, and finding effective treatment options often proves to be quite difficult. The symptoms can severely impact the quality of life of those affected, resulting in considerable disability. This systematic review aims to compare available medical treatments for EM by evaluating their efficacy and safety. Materials and Methods: Following PRISMA guidelines, the search included the PubMed, Medline, and Web of Science databases, using the keywords (\u201cErythromelalgia\u201d OR \u201cMitchell\u2019s Disease\u201d) AND (\u201cErythromelalgia Treatment\u201d OR \u201cErythromelalgia Management\u201d). Results: From the 103 papers extracted through the database search, six articles were considered suitable for the systematic review. The included studies investigated various interventions used for a total of 120 patients, including iloprost (n = 8), misoprostol (n = 21), topical amitriptyline-ketamine (n = 36), lidocaine (n = 27), chemical lumbar sympathectomy (CLS, n = 13), and various pharmacological agents (n = 11). The outcomes showed significant improvements in areas like pain reduction, cooling scores, and temperature regulation. Iloprost and misoprostol exhibited notable benefits in cooling scores, sympathetic dysfunction, and EM severity compared to placebos. About 75% of the patients reported pain relief with topical amitriptyline-ketamine, while lidocaine reduced nociceptive feelings in a dose-dependent manner. Conclusions: Comparing interventions demonstrated consistent clinical benefit with varied tolerability. However, adverse events ranged from mild gastrointestinal symptoms to severe complications such as disability and depression, requiring careful monitoring. Given EM\u2019s diverse symptoms and comorbidities, treatment efficacy varies among individuals. A personalized approach incorporating genetic testing, multidisciplinary care, and long-term monitoring is essential to optimize outcomes. Continued research is vital to advance understanding of EM\u2019s pathophysiology and improve patient care.<\/jats:p>","DOI":"10.3390\/medicina61050920","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T08:41:12Z","timestamp":1747730472000},"page":"920","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative Efficacy and Tolerability of Treatments for Erythromelalgia: A Systematic Review"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9802-5852","authenticated-orcid":false,"given":"Abdullah S.","family":"Algarni","sequence":"first","affiliation":[{"name":"Department of Medicine, College of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem M.","family":"Alharthi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Al-Baha University, Al-Aqiq 65522, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaden O.","family":"Alqurashi","sequence":"additional","affiliation":[{"name":"Collage of Medicine, Taif University, Taif 21944, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0199-7597","authenticated-orcid":false,"given":"Ruba M.","family":"Alghanmi","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8982-4876","authenticated-orcid":false,"given":"Rimaz R.","family":"Aldawsari","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysaa A.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5912-9667","authenticated-orcid":false,"given":"Ramy","family":"Samargandi","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archderm.136.3.330","article-title":"Natural History of Erythromelalgia: Presentation and Outcome in 168 Patients","volume":"136","author":"Davis","year":"2000","journal-title":"Arch. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2796.1997.00185.x","article-title":"Erythromelalgia: A Clinical Study of 87 Cases","volume":"242","author":"Kalgaard","year":"1997","journal-title":"J. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, Encoding a Sodium Channel Alpha Subunit, in Patients with Primary Erythermalgia","volume":"41","author":"Yang","year":"2004","journal-title":"J. Med. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.0602813103","article-title":"A Single Sodium Channel Mutation Produces Hyper- or Hypoexcitability in Different Types of Neurons","volume":"103","author":"Rush","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/brain\/aww007","article-title":"Inherited Erythromelalgia Due to Mutations in SCN9A: Natural History, Clinical Phenotype and Somatosensory Profile","volume":"139","author":"McDonnell","year":"2016","journal-title":"Brain J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.molmed.2005.10.004","article-title":"Erythermalgia: Molecular Basis for an Inherited Pain Syndrome","volume":"11","author":"Waxman","year":"2005","journal-title":"Trends Mol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2133.2005.06441.x","article-title":"Genetic Heterogeneity and Exclusion of a Modifying Locus at 2q in a Family with Autosomal Dominant Primary Erythermalgia","volume":"153","author":"Burns","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ced.13891","article-title":"Review of Primary and Secondary Erythromelalgia","volume":"44","author":"Mann","year":"2019","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0065-2660(08)01004-3","article-title":"Genetics and Molecular Pathophysiology of Na(v)1.7-Related Pain Syndromes","volume":"63","author":"Yang","year":"2008","journal-title":"Adv. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/brain\/awr143","article-title":"Deletion Mutation of Sodium Channel Na(V)1.7 in Inherited Erythromelalgia: Enhanced Slow Inactivation Modulates Dorsal Root Ganglion Neuron Hyperexcitability","volume":"134","author":"Cheng","year":"2011","journal-title":"Brain J. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2147\/JPR.S154462","article-title":"Current Pain Management Strategies for Patients with Erythromelalgia: A Critical Review","volume":"11","author":"Tham","year":"2018","journal-title":"J. Pain Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archderm.142.3.283","article-title":"Combination Gel of 1% Amitriptyline and 0.5% Ketamine to Treat Refractory Erythromelalgia Pain: A New Treatment Option?","volume":"142","author":"Sandroni","year":"2006","journal-title":"Arch. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1752-1947-8-69","article-title":"An Egyptian Child with Erythromelalgia Responding to a New Line of Treatment: A Case Report and Review of the Literature","volume":"8","year":"2014","journal-title":"J. Med. Case Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13643-017-0663-8","article-title":"Evaluations of the Uptake and Impact of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement and Extensions: A Scoping Review","volume":"6","author":"Page","year":"2017","journal-title":"Syst. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A Tool for Assessing Risk of Bias in Non-Randomised Studies of Interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.0022-202X.2004.22339.x","article-title":"The Prostaglandin E1 Analog Misoprostol Reduces Symptoms and Microvascular Arteriovenous Shunting in Erythromelalgia-a Double-Blind, Crossover, Placebo-Compared Study","volume":"122","author":"Salerud","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/00015550310015031","article-title":"Prostacyclin Reduces Symptoms and Sympathetic Dysfunction in Erythromelalgia in a Double-Blind Randomized Pilot Study","volume":"83","author":"Kalgaard","year":"2003","journal-title":"Acta Derm. Venereol."},{"key":"ref_19","first-page":"308","article-title":"Topical Amitriptyline Combined with Ketamine for the Treatment of Erythromelalgia: A Retrospective Study of 36 Patients at Mayo Clinic","volume":"12","author":"Poterucha","year":"2013","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ejp.1030","article-title":"Pain Thresholds, Supra-Threshold Pain and Lidocaine Sensitivity in Patients with Erythromelalgia, Including the I848Tmutation in NaV 1.7","volume":"21","author":"Sagafos","year":"2017","journal-title":"Eur. J. Pain Lond. Engl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jvs.2018.05.226","article-title":"Chemical Lumbar Sympathectomy in the Treatment of Recalcitrant Erythromelalgia","volume":"68","author":"Wang","year":"2018","journal-title":"J. Vasc. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2023191","DOI":"10.5826\/dpc.1303a191","article-title":"Clinical Challenges in Primary Erythromelalgia: A Real-Life Experience from a Single Center and a Diagnostic-Therapeutic Flow-Chart Proposal","volume":"13","author":"Michelerio","year":"2023","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11910-011-0233-8","article-title":"Pain Disorders and Erythromelalgia Caused by Voltage-Gated Sodium Channel Mutations","volume":"12","author":"Dabby","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M117.778779","article-title":"Gain-of-Function Mutation of a Voltage-Gated Sodium Channel NaV1.7 Associated with Peripheral Pain and Impaired Limb Development","volume":"292","author":"Tanaka","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/pme.12030","article-title":"Erythromelagia: A Rare and Hard-to-Treat Condition: A 9-Year-Old Boy Responsive to Intravenous Lidocaine and Oral Mexilitene","volume":"14","author":"Elgueta","year":"2013","journal-title":"Pain Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-0031-1287823","article-title":"Primary Erythromelalgia in a 12-Year-Old Boy: Positive Response to Sodium Channel Blockers despite Negative SCN9A Mutations","volume":"224","author":"Jakob","year":"2012","journal-title":"Klin. Padiatr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1111\/bph.12788","article-title":"Mexiletine as a Treatment for Primary Erythromelalgia: Normalization of Biophysical Properties of Mutant L858F NaV 1.7 Sodium Channels","volume":"171","author":"Cregg","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1744-8069-3-3","article-title":"Temperature Dependence of Erythromelalgia Mutation L858F in Sodium Channel Nav1.7","volume":"3","author":"Han","year":"2007","journal-title":"Mol. Pain"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ana.22485","article-title":"Gain of Function Na\u03bd1.7 Mutations in Idiopathic Small Fiber Neuropathy","volume":"71","author":"Faber","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_30","first-page":"80","article-title":"Clinical Features and Management of Erythromelalgia: Long Term Follow-up of 46 Cases","volume":"35","author":"Parker","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1067\/mjd.2000.109301","article-title":"Erythromelalgia: New Theories and New Therapies","volume":"43","author":"Cohen","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","first-page":"763","article-title":"Long-Term Remission of Primary Erythermalgia with R1150W Polymorphism in SCN9A after Chemical Lumbar Sympathectomy","volume":"20","author":"Zhang","year":"2010","journal-title":"Eur. J. Dermatol. EJD"},{"key":"ref_33","first-page":"1320","article-title":"Lidocaine Patch for Pain of Erythromelalgia: Follow-up of 34 Patients","volume":"141","author":"Davis","year":"2005","journal-title":"Arch. Dermatol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/920\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:35:22Z","timestamp":1760031322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["medicina61050920"],"URL":"https:\/\/doi.org\/10.3390\/medicina61050920","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}